Harvard Bioscience Current Ratio 2010-2024 | HBIO

Harvard Bioscience current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Harvard Bioscience Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-12-31 $0.05B $0.06B 0.82
2024-09-30 $0.05B $0.02B 2.06
2024-06-30 $0.05B $0.02B 2.05
2024-03-31 $0.05B $0.03B 1.88
2023-12-31 $0.05B $0.03B 1.85
2023-09-30 $0.05B $0.02B 2.09
2023-06-30 $0.05B $0.02B 2.29
2023-03-31 $0.05B $0.02B 2.26
2022-12-31 $0.05B $0.02B 2.20
2022-09-30 $0.05B $0.02B 2.43
2022-06-30 $0.06B $0.02B 2.42
2022-03-31 $0.06B $0.03B 2.18
2021-12-31 $0.06B $0.03B 2.43
2021-09-30 $0.06B $0.02B 2.37
2021-06-30 $0.05B $0.02B 2.30
2021-03-31 $0.05B $0.02B 2.38
2020-12-31 $0.05B $0.02B 2.46
2020-09-30 $0.04B $0.02B 2.05
2020-06-30 $0.04B $0.02B 1.95
2020-03-31 $0.05B $0.02B 2.05
2019-12-31 $0.05B $0.03B 2.12
2019-09-30 $0.05B $0.02B 2.41
2019-06-30 $0.05B $0.02B 2.52
2019-03-31 $0.05B $0.02B 2.22
2018-12-31 $0.06B $0.03B 2.27
2018-09-30 $0.06B $0.02B 2.83
2018-06-30 $0.05B $0.02B 2.42
2018-03-31 $0.06B $0.02B 2.50
2017-12-31 $0.05B $0.01B 3.39
2017-09-30 $0.05B $0.01B 3.40
2017-06-30 $0.05B $0.01B 3.46
2017-03-31 $0.05B $0.01B 3.21
2016-12-31 $0.05B $0.02B 3.11
2016-09-30 $0.05B $0.01B 3.20
2016-06-30 $0.05B $0.02B 3.15
2016-03-31 $0.05B $0.02B 3.07
2015-12-31 $0.05B $0.02B 2.62
2015-09-30 $0.05B $0.02B 3.03
2015-06-30 $0.06B $0.02B 2.66
2015-03-31 $0.05B $0.02B 2.67
2014-12-31 $0.06B $0.02B 3.15
2014-09-30 $0.07B $0.02B 4.16
2014-06-30 $0.06B $0.02B 3.94
2014-03-31 $0.06B $0.02B 3.96
2013-12-31 $0.06B $0.02B 3.78
2013-09-30 $0.07B $0.01B 5.48
2013-06-30 $0.07B $0.01B 5.47
2013-03-31 $0.06B $0.01B 4.72
2012-12-31 $0.06B $0.01B 5.96
2012-09-30 $0.06B $0.01B 6.17
2012-06-30 $0.06B $0.01B 5.88
2012-03-31 $0.06B $0.01B 5.45
2011-12-31 $0.06B $0.01B 6.02
2011-09-30 $0.06B $0.01B 5.72
2011-06-30 $0.06B $0.01B 6.08
2011-03-31 $0.06B $0.01B 5.58
2010-12-31 $0.06B $0.01B 5.19
2010-09-30 $0.05B $0.01B 5.42
2010-06-30 $0.05B $0.01B 4.63
2010-03-31 $0.05B $0.01B 4.03
2009-12-31 $0.05B $0.01B 3.93
2009-09-30 $0.05B $0.02B 2.12
2009-06-30 $0.04B $0.01B 4.80
2009-03-31 $0.04B $0.01B 4.28
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.041B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $7.866B 21.53
Kewaunee Scientific (KEQU) United States $0.156B 11.44